KPV vs Palmitoyl Tripeptide-1

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

KPV

KPV is a tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (α-MSH). It retains the potent anti-inflammatory properties of the parent hormone without the tanning or other melanocortin effects.

Full details →

Palmitoyl Tripeptide-1

Palmitoyl Tripeptide-1 (Pal-GHK) is a lipopeptide that stimulates collagen production. It's one of two peptides in the Matrixyl 3000 complex, working synergistically with Palmitoyl Tetrapeptide-7.

Full details →

Side-by-Side Comparison

AspectKPVPalmitoyl Tripeptide-1
MechanismInhibits NF-κB activation and reduces inflammatory cytokine production. Enters cells and directly modulates inflammatory signaling without requiring melanocortin receptors.Mimics the skin's own mechanism for producing collagen by acting as a messenger peptide that signals fibroblasts to produce more collagen and other extracellular matrix components.
Typical DosageOral/sublingual: 200-500mcg 1-3 times daily. Topical formulations for localized inflammation. Also used in enemas for gut inflammation.Topical: Typically 2-4% in serums, often combined with Palmitoyl Tetrapeptide-7 as Matrixyl 3000.
AdministrationCan be taken orally, sublingually, or as suppositories/enemas for gut inflammation. Topical use for skin conditions. Stable orally unlike most peptides.Topical application 1-2 times daily. The palmitoyl group enhances skin penetration compared to non-lipidated versions.
Side EffectsGenerally very well-tolerated. Minimal systemic effects due to targeted anti-inflammatory action.Very well-tolerated. Suitable for most skin types including sensitive skin.
Best For

What They Have in Common

Both KPV and Palmitoyl Tripeptide-1 are commonly used for:

Key Differences

Unique to KPV:

Unique to Palmitoyl Tripeptide-1:

Ready to Learn More?